Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer - Contacts and Locations

Home

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

This study has been suspended.

Study NCT00281125. Last updated on September 6, 2006. Information provided by Nevada Cancer Institute

Please refer to this study by its ClinicalTrials.gov identifier: NCT00281125

Locations


United States, Nevada
	Nevada Cancer Institute
	Las Vegas, Nevada, United States, 89135

Sponsors and Collaborators

Nevada Cancer Institute

Investigators


Principal Investigator:	Sunil Sharma, MD	Nevada Cancer Institute